.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Precision Medicine in Breast Cancer

EP. 1: HER2-Targeted Therapy in Early Breast Cancer

November 11th 2016

EP. 2: Neoadjuvant Combinations in HER2+ Breast Cancer

November 11th 2016

EP. 3: Neoadjuvant Lapatinib in HER2+ Early Breast Cancer

November 11th 2016

EP. 4: Neoadjuvant T-DM1 in HER2+ Early Breast Cancer

November 11th 2016

EP. 5: Treatment of HER2+ Metastatic Breast Cancer

November 11th 2016

EP. 6: Novel Strategies for HER2+ Metastatic Breast Cancer; Biosimilars

November 11th 2016

EP. 7: Neratinib in HER2+ Breast Cancer

November 11th 2016

EP. 8: Ongoing Needs in HER2+ Breast Cancer

November 11th 2016

EP. 9: HR+ Breast Cancer: FALCON

November 11th 2016

EP. 10: Progression of HR+ Metastatic Breast Cancer

November 11th 2016

EP. 11: Biomarkers for CDK4/6 Inhibitors

November 11th 2016

EP. 12: HER2 Mutations in Breast Cancer

November 11th 2016

EP. 13: PI3K Inhibitors for HR+ Breast Cancer

November 11th 2016